4//SEC Filing
Dar Zavain 4
Accession 0001601830-24-000029
CIK 0001601830other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 5:43 PM ET
Size
5.2 KB
Accession
0001601830-24-000029
Insider Transaction Report
Form 4
Dar Zavain
Director
Transactions
- Award
Class A Common Stock
2024-04-01+1,467→ 89,056 total
Footnotes (2)
- [F1]Shares were issued pursuant to the Issuer's Outside Director Compensation Policy.
- [F2]Includes a total of 32,373 shares received pursuant to a pro-rata distribution from Lux Ventures, of which the Reporting Person was a limited partner. The acquisition of such shares was exempt pursuant to Rule 16a-9 and was inadvertently excluded from the total amount of shares held on the Reporting Person's Forms 4 since July 12, 2023.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001852075
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 5:43 PM ET
- Size
- 5.2 KB